Early and Late Histological and Ultrastructural Findings in Resected Infantile Capillary Hemangiomas Following Treatment with Topical Beta-Blocker Timolol Maleate 0.5. [PDF]
Sipkova Z +4 more
europepmc +1 more source
Topical Timolol for Peritoneal Dialysis Catheter Exit-Site Granulomas: First Report of Successful Use in CAPD Patients. [PDF]
S VM +4 more
europepmc +1 more source
Machine learning-driven drug repurposing for HER2-positive breast cancer. [PDF]
Dinesh BGH +8 more
europepmc +1 more source
Topical Timolol Beyond Infancy: A Retrospective Study of Its Use in Persistent Infantile Hemangiomas. [PDF]
Bogomolets O, Bogomolets-Sheremetieva S.
europepmc +1 more source
Topical timolol maleate: An effectual and safe recourse for infantile hemangiomas.
Bhat YJ, Yaseen A, Hassan I.
europepmc +1 more source
Real-world efficacy, safety, and usability of a microvolume eyedrop delivery device in glaucoma: prospective randomized crossover trial. [PDF]
Steger JS +8 more
europepmc +1 more source
Latanoprost/timolol fixed-dose combination: two decades of efficacy and safety in glaucoma management. [PDF]
Martinez-de-la-Casa J +5 more
europepmc +1 more source
Limbal stem cell deficiency secondary to topical glaucoma medication: a scoping review. [PDF]
Liu AWY, Wan Abdul Halim WH, Md Din N.
europepmc +1 more source
Vitreous membranes post parsplana vitrectomy. [PDF]
Kasi K, Rao S, Shaikh N.
europepmc +1 more source

